Navigation Links
Hologic Announces Fourth Quarter Fiscal 2013 Operating Results
Date:11/11/2013

on‐GAAP results is included as an attachment to this press release.

Fourth Quarter Fiscal 2013 Operating Results Overview: Fourth quarter fiscal 2013 revenues increased 5.7% to $622.1 million from $588.5 million in the prior year. During the same period, non-GAAP revenues increased 3.7% from $600.2 million. Non-GAAP revenues in the fourth quarter of fiscal 2012 reflect the addition of $11.6 million relating to contingent revenue earned and received under the Company's collaboration agreement with Novartis that was eliminated as a result of the effect of purchase accounting.

The increase in revenues compared to the same period in the prior year was driven primarily by:

  • The inclusion of a full quarter of Gen-Probe revenues (compared to approximately two months in the prior year);
  • Record U.S. placements of 3D Dimensions tomosynthesis systems;
  • Higher sales of MyoSure hysteroscopic tissue removal (MyoSure) systems; and
  • An increase in service revenues from the Company's increased installed base of digital mammography systems.
  • The overall revenue increase was partially offset by lower year-over-year sales of:

  • Legacy Hologic Diagnostics products, primarily the ThinPrep pap test;
  • NovaSure endometrial ablation (NovaSure) systems;
  • Sales from the divested Lifecodes business;
  • 2D mammography systems as buyers shift to 3D systems; and
  • Skeletal Health products.
  • Foreign currencies had a negligible impact on revenues compared with the fourth quarter of fiscal 2012.

    Fourth quarter fiscal 2013 net loss was $1.1 billion, or $(4.11) per diluted share, compared with a net loss of $77.8 million, or $(0.29) per diluted share, in the fourth quarter of fiscal 2012. Fourth quarter fiscal 2013 non-GAAP net income was $107.6 million, or $0.39 per diluted share, an increase of 9.4% and 7.1%, respectively, compared to $98.3 million, or $0.37 per diluted share, for th
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. Hologic, Inc. Enhances Physician Training With Virtual Reality Simulation
    2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
    3. Hologic to Host Investor Presentation at RSNA 2013
    4. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
    5. Hologic to Present at Two Upcoming Investor Conferences
    6. Hologic Announces Third Quarter Fiscal 2013 Operating Results
    7. Hologic Announces Completion of Term Loan B Repricing
    8. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
    9. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
    10. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
    11. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental ... order to treat dental impairments, for tooth restoration and ...
    (Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health care ... new IT value-added reseller (VAR) national contracts that expand ... and services at lower costs. These include manufacturer product ... as initiative assistance and ongoing IT consulting support. ...
    (Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
    Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
    ... MPMN and PlasticsToday.com, both leading news and ... today announced the launch of a new conference on ... the latest technological and regulatory developments in the use ... sustained growth despite broader economic difficulties, the value of ...
    ... N.J., Oct. 10, 2011 Cantel Medical Corp. (NYSE: ... quarter and fiscal year ended July 31, 2011 on Thursday, ... call to discuss the results at 11:00 AM ET.  Participating ... A. Krakauer, President and CEO; Seth R. Segel, Executive Vice ...
    Cached Medicine Technology:MPMN and PlasticsToday Launch New Specialist Conference on Innovations in Medical Polymers 2Cantel Medical Corp. to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2011 Results 2
    (Date:4/24/2014)... corresponding terminology, and the relevance of palliation in ... on randomized controlled trials (RCTs). This is the ... for Quality and Efficiency in Health Care (IQWiG), ... , Together with external experts, IQWiG analysed studies ... cancer, malignant melanoma, and pancreatic cancer. For this ...
    (Date:4/24/2014)... has been awarded one of 30 grants from the ... Academic Participating Site in its new National Clinical ... select groups of investigators charged with distributing resources in ... NCTN grant system reflects recommendations from a 2010 ... achieve four goals:, Faster design, launch, and ...
    (Date:4/23/2014)... Hospital (MGH) investigators may lead to greater availability and ... problem use of fecal material from healthy donors ... difficile ( C. difficile ) bacteria. In ... Clinical Infectious Diseases , the researchers report that use ... patients was as successful in curing recurrent C. ...
    (Date:4/23/2014)... National Institute of Arthritis and Musculoskeletal and Skin Diseases ... Ross Prize in Molecular Medicine, conferred by the Feinstein ... award will be given on June 9 at the ... scientific presentations by Dr. O,Shea and other prominent researchers. ... , The award, which includes a $50,000 prize from ...
    (Date:4/23/2014)... pathway that helps prevent new cells from receiving too ... been directly linked to cancer and other diseases. , ... the end of cell division, the enzyme Cdc14 activates ... are fully repaired before the parent cell distributes copies ... safeguard against some of the most devastating genome errors, ...
    Breaking Medicine News(10 mins):Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
    ... Older African American women who have experienced high levels ... to suffer worse physical and mental health than their ... of the Journal of Women,s Health . , ... health issues such as depression and anxiety, and more ...
    ... Following a review by The Lancet of the ... of Cardiology has reaffirmed its advice about the risks of ... , is increased "up to four-fold" by long-haul flight. , ... flying is associated with an increase in deep venous thrombosis, ...
    ... flights in 9 minutes, 31 secondsCHICAGO, Feb. 23 Over ... Hancock stair climb event on Sunday, February 22. They did ... lung disease, the third leading cause of death and disability ... raise more than $1 million to benefit Respiratory Health Association ...
    ... VANCOUVER, Feb. 24 /PRNewswire-FirstCall/ - CRH Medical Corporation announced ... Hemorrhoid banding technology has been adopted by more than ... Company since June 2008. The Company believes this provides ... but also confirmation of the consistency of its training ...
    ... new survey from global market research firm Synovate shows that less than ... months. Of those, only 10% received it at a pharmacy and just ... ... February 24, 2009 -- According to a new survey by leading market ...
    ... Online-Only Event Brings Together Leading Cardiovascular ExpertsLAS ... Inc. (NMT), an award-winning company engaged in ... today announced that the Company will be ... medical assessment and communications products at CardioCareLive, ...
    Cached Medicine News:Health News:Triple threat to health 2Health News:ESC reaffirms advice on cardiovascular risks associated with long-haul flights 2Health News:Over 4,000 Hustle Up the Hancock to Fight Lung Disease 2Health News:CRH provides Partnership Program update 2Health News:New survey: Flu Shot Still not Catching on, Especially at Retail Clinics 2Health News:Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference 2Health News:Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference 3
    ... Mesh Self-Forming Plug is a mesh plug ... well as primary inguinal hernias and femoralhernias. ... defect and fills it completely. Premilene Mesh ... of the established Premilene Mesh. The plug ...
    ... The Celsius Control System provides ... can safely,and rapidly lower patient ... target temperature and,rewarm patients to ... System consists of an endovascular,catheter, ...
    ... , it maximizes use by allowing ... it, while the third lamp is ... care in mind, it includes universal ... An excellent choice for hospital operating ...
    ... Perfectly balanced, the patented Orion incorporates ... that illuminates brilliantly. The fully adjustable ... designed to sit low on the brow, ... vision. Two clips on the headband ...
    Medicine Products: